- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2023–2028 · research · R01
Germline mutagenesis at meiotic double-strand breaks
Maria Jasin · Kettering University · funded by National Institutes of Health
2023–2027 · research · R37
Defining the function of Complex I truncating mutations in cancer
Payam Gammage · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2023–2028 · training · T32
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)
Jonine L. Bernstein · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease
Viviane Tabar · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2023–2028 · research · R00
Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems
Naama Aviram · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Mechanisms of racial disparity in breast cancer-related lymphedema
Andrea Barrio · Kettering University · funded by National Institutes of Health
2023–2028 · career development · K08
Advanced machine learning to empower ultra-sensitive liquid biopsy in melanoma and non-small cell lung cancer
Adam Widman · Kettering University · funded by National Institutes of Health
2023–2027 · research · R37
Probabilistic Multiscale Modeling of the Tumor Microenvironment
Wesley Tansey · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
TOX-driven CD8 T cell differentiation and dysfunction in tumors
Andrea Schietinger · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
Ping Chi · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Reflectance confocal microscopy-optical coherence tomography (RCM-OCT) imaging of oral lesions: Toward an affordable device and approach for developing countries
Pankaj Chaturvedi · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
Christopher Austin Klebanoff · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer
Sohrab P Shah · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Investigating telomerase dynamics in live cells at a single-molecule level
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer
Monica Morrow · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Chemical Genetic Dissection of SWI/SNF Chromatin Remodeling Complex Functions in Cerebral Cortex Development
Thomas S Vierbuchen · Kettering University · funded by National Institutes of Health
2023–2028 · research · R01
Selective interactome vulnerability across the Alzheimer’s disease spectrum
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2023–2027 · research · R01
Targeting plasticity in lung cancer
Tuomas Tammela · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2022–2026 · research · R37
Immune control and genomic instability at micronuclei
John Maciejowski · Kettering University · funded by National Institutes of Health
2022–2024 · research · R21
Advanced planar image reconstruction for targeted alpha therapy
Charles Ross Schmidtlein · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Determining the role and function of a high plasticity cell state in lung adenocarcinoma
Jason Earl Chan · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
Andreas Rimner · Kettering University · funded by National Institutes of Health
2022–2026 · career development · K00
Investigating the Role of Cell Plasticity in Malignant Transformation
Andrea Christine Chaikovsky · Kettering University · funded by National Institutes of Health
2022–2025 · research · R01
Circulating biomarkers of ALK+ anaplastic large cell lymphoma
Megan S. Lim · Kettering University · funded by National Institutes of Health
2022–2025 · research · R21
Enhancing Health Cost Literacy and Financial Capability among Young Adult Cancer Survivors
Danielle Friedman · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe
Michael J Morris · Kettering University · funded by National Institutes of Health
2022–2027 · research · R37
Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer
Eugene Pietzak · Kettering University · funded by National Institutes of Health
2022–2023 · grant · S10
Bruker AV-NEO Console for 7T MRI
Hongbiao Carl Lekaye · Kettering University · funded by National Institutes of Health
2022–2025 · research · R21
Molecular mechanisms of age-related lymphatic dysfunction
Babak J Mehrara · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:
Paul Christopher Boutros · Kettering University · funded by National Institutes of Health
2022–2025 · research · R01
Genomic biomarkers for cutaneous T-cell Lymphoma
Megan S. Lim · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ping Chi · Kettering University · funded by U.S. Food and Drug Administration
2022–2026 · career development · K08
Assessing lineage infidelity, oncogenic cooperativity and dependency in RUNX1-mutant acute myeloid leukemia
Wenbin Xiao · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
Yu Chen · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Spatial characterization of the tumor-immune microenvironment in SMARCB1-deficient epithelioid sarcomas
Christina S Leslie · Kettering University · funded by National Institutes of Health